These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1125 related articles for article (PubMed ID: 3812082)

  • 1. Antitumor activity and biochemistry of novel analogs of the antibiotic, CC-1065.
    Wierenga W; Bhuyan BK; Kelly RC; Krueger WC; Li LH; McGovren JP; Swenson DH; Warpehoski MA
    Adv Enzyme Regul; 1986; 25():141-55. PubMed ID: 3812082
    [No Abstract]   [Full Text] [Related]  

  • 2. CC-1065 (NSC 298223), a most potent antitumor agent: kinetics of inhibition of growth, DNA synthesis, and cell survival.
    Bhuyan BK; Newell KA; Crampton SL; Von Hoff DD
    Cancer Res; 1982 Sep; 42(9):3532-7. PubMed ID: 7105029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoelectronic factors influencing the biological activity and DNA interaction of synthetic antitumor agents modeled on CC-1065.
    Warpehoski MA; Gebhard I; Kelly RC; Krueger WC; Li LH; McGovren JP; Prairie MD; Wicnienski N; Wierenga W
    J Med Chem; 1988 Mar; 31(3):590-603. PubMed ID: 3346875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the structural features of (+)-CC-1065 that are responsible for bending and winding of DNA.
    Lee CS; Sun D; Kizu R; Hurley LH
    Chem Res Toxicol; 1991; 4(2):203-13. PubMed ID: 1782349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and activity relationship of several novel CC-1065 analogs.
    Li LH; Wallace TL; DeKoning TF; Warpehoski MA; Kelly RC; Prairie MD; Krueger WC
    Invest New Drugs; 1987 Dec; 5(4):329-37. PubMed ID: 3436738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CC-1065 (NSC 298223), a novel antitumor agent that interacts strongly with double-stranded DNA.
    Li LH; Swenson DH; Schpok SL; Kuentzel SL; Dayton BD; Krueger WC
    Cancer Res; 1982 Mar; 42(3):999-1004. PubMed ID: 6174220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of CC-1065 and its analogues with mouse DNA and chromatin.
    Moy BC; Prairie MD; Krueger WC; Bhuyan BK
    Cancer Res; 1989 Apr; 49(8):1983-8. PubMed ID: 2702639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of U-71,184 and several other CC-1065 analogues on cell survival and cell cycle of Chinese hamster ovary cells.
    Adams EG; Badiner GJ; Bhuyan BK
    Cancer Res; 1988 Jan; 48(1):109-16. PubMed ID: 2446739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA sequence recognition by the antitumor antibiotic CC-1065 and analogs of CC-1065.
    Krueger WC; Hatzenbuhler NT; Prairie MD; Shea MH
    Chem Biol Interact; 1991; 79(3):265-86. PubMed ID: 1913973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of interaction of CC-1065 (NSC 298223) with DNA.
    Swenson DH; Li LH; Hurley LH; Rokem JS; Petzold GL; Dayton BD; Wallace TL; Lin AH; Krueger WC
    Cancer Res; 1982 Jul; 42(7):2821-8. PubMed ID: 7083173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaction of the antitumor antibiotic CC-1065 with DNA: structure of a DNA adduct with DNA sequence specificity.
    Hurley LH; Reynolds VL; Swenson DH; Petzold GL; Scahill TA
    Science; 1984 Nov; 226(4676):843-4. PubMed ID: 6494915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibility of the covalent reaction of CC-1065 and analogues with DNA.
    Warpehoski MA; Harper DE; Mitchell MA; Monroe TJ
    Biochemistry; 1992 Mar; 31(9):2502-8. PubMed ID: 1547233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, cytotoxicity and antitumor activity of some new simplified pyrazole analogs of the antitumor agent CC-1065. Effect of an hydrophobic group on antitumor activity.
    Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Zaid AN; Cozzi P; Geroni C; Mongelli N
    Farmaco; 1997 Dec; 52(12):711-6. PubMed ID: 9648274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CC-1065 (NSC 298223), a potent new antitumor agent improved production and isolation, characterization and antitumor activity.
    Martin DG; Biles C; Gerpheide SA; Hanka LJ; Krueger WC; McGovren JP; Mizsak SA; Neil GL; Stewart JC; Visser J
    J Antibiot (Tokyo); 1981 Sep; 34(9):1119-25. PubMed ID: 7328053
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential antitumor agents. I. Synthesis of pyrroloindazole derivatives related to the pyrroloindole moieties of the antitumor antibiotic CC-1065.
    Massa S; Stefancich G; Artico M; Corelli F; Silvestri R
    Farmaco Sci; 1987 Aug; 42(8):567-74. PubMed ID: 3666127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+)-CC-1065 produces bending of DNA that appears to resemble adenine/thymine tracts.
    Lin CH; Sun DY; Hurley LH
    Chem Res Toxicol; 1991; 4(1):21-6. PubMed ID: 1655087
    [No Abstract]   [Full Text] [Related]  

  • 17. CC-1065 functional analogues possessing different electron-withdrawing substituents and leaving groups: synthesis, kinetics, and sequence specificity of reaction with DNA and biological evaluation.
    Wang Y; Gupta R; Huang L; Lown JW
    J Med Chem; 1993 Dec; 36(26):4172-82. PubMed ID: 8277498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle effects of CC-1065.
    Bhuyan BK; Crampton SL; Adams EG
    Cancer Res; 1983 Sep; 43(9):4227-32. PubMed ID: 6871861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of a pronounced effect of noncovalent binding selectivity on the (+)-CC-1065 DNA alkylation and identification of the pharmacophore of the alkylation subunit.
    Boger DL; Zarrinmayeh H; Munk SA; Kitos PA; Suntornwat O
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1431-5. PubMed ID: 1847523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of nicotinamide adenine dinucleotide in normal and xeroderma pigmentosum fibroblast cells by the antitumor drug CC-1065.
    Jacobson MK; Twehous D; Hurley LH
    Biochemistry; 1986 Oct; 25(20):5929-32. PubMed ID: 3790494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.